All In Biotech

Drug Trial Radar · NCT01306331

Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel

A Multicenter, Open-Label, Randomized Study of the Contraceptive Efficacy and Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel

Last checked: Nov 19, 2026Latest source record: Jul 12, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 3,389 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

3,389

Actual

Start

Apr 2011

Primary completion

Jun 2014

Study completion Jun 2014

Sponsor

Lead sponsor
Evofem Inc.Industry
Sponsor type
Industry
Collaborators
Premier Research
First posted
Mar 1, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
Female only, from 18 years, up to 35 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a research study of a new experimental vaginal gel that helps in vaginal pH regulation and results in immobilization of spermatozoa by maintaining the normally low vaginal pH, even in the presence of semen. This vaginal gel is called Phexxi™ (previously known as Amphora) and was compared to a commercially available spermicide called Conceptrol®, which contains nonoxynol 9; commonly abbreviated as N-9. Conceptrol® can help prevent pregnancy. This study objective was to determine if this product prevents pregnancy when inserted into the vagina before intercourse.

Conditions

  • Contraception

Interventions

  • ConceptrolDrug

    • Conceptrol® Vaginal Gel, which contains 100 mg (4% concentration) of nonoxynol-9 (N-9) in 2.5 mL volume of gel.

  • AmphoraDrug

    • Amphora™ gel, which will be delivered in 5 mL doses, is a clear, water-based, petroleum-free gel.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 6-Month (183 Days) Cumulative Pregnancy PercentageTime frame: 183 days

Locations

52 sites in 2 countries. Site status is shown where the registry gives one.

  • Alabama Clinical Therapeutics, LLC

    Birmingham, Alabama

  • Lynn Institute of the Ozarks

    Little Rock, Arkansas

  • Advanced Clinical Research Institute

    Anaheim, California

  • Anaheim Clinical Trials, LLC

    Anaheim, California

  • California Family Health Council, Inc.

    Berkeley, California

  • California Family and Health Council, Inc., LA

    Los Angeles, California

  • California Family Health Council

    Los Angeles, California

  • Women's Health Care

    San Diego, California

  • Downtown Women's Healthcare

    Denver, Colorado

  • Planned Parenthood of the Rocky Mountains

    Denver, Colorado

  • Stamford Therapeutics Consortium

    Stamford, Connecticut

  • Meridien Research

    Bradenton, Florida

  • Avail Clinical Reseach

    DeLand, Florida

  • Altus Research

    Lake Worth, Florida

  • Miami Research Associates

    Miami, Florida

  • Segal Institute for Clinical Research

    North Miami, Florida

  • Meridien Research

    St. Petersburg, Florida

  • Comprehensive Clinical Trials

    West Palm Beach, Florida

  • Soapstone Center for Clinical Research

    Decatur, Georgia

  • Rosemark WomenCare Specialist

    Idaho Falls, Idaho

  • Heartland Research Associates, LLC

    Wichita, Kansas

  • Johns Hopkins Community Physicians

    Baltimore, Maryland

  • Impact Clinical Trials

    Las Vegas, Nevada

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire

  • NYU Medical Center Family Planning

    New York, New York

  • Columbia University Medical Center, Division of Family Planning

    New York, New York

  • Eastern Carolina Women's Center

    New Bern, North Carolina

  • Wake Research Associates

    Raleigh, North Carolina

  • University of Cincinnati

    Cincinnati, Ohio

  • Planned Parenthood of Northeast Ohio

    Cleveland, Ohio

  • Oregon Health Sciences University

    Portland, Oregon

  • University of Pennsylvania Medical Center, Reproductive Research Unit

    Philadelphia, Pennsylvania

  • Philadelphia Clinical Research

    Philadelphia, Pennsylvania

  • Magee-Womens Hospital

    Pittsburgh, Pennsylvania

  • Advanced Research Associates

    Corpus Christi, Texas

  • Practice Research Organization

    Dallas, Texas

  • UT Southwestern Medical Center - Dept. of OB/GYN

    Dallas, Texas

  • TMC Life Research, Inc

    Houston, Texas

  • MacArthur OB/GYN

    Irving, Texas

  • Jean Brown Research

    Salt Lake City, Utah

Showing 40 of 52 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.